Convergence Medical Products has produced partnerships with several neuromuscular disease agencies, which plan to utilize the company’s investigational EIM gadget in future medical trials. These include agreements with Charley’s Fund and the Nash Avery Base, two leading companies which provide research funding to find a treatment for Duchenne Muscular Dystrophy , and the Northeast ALS Consortium, several leading physicians focused on ALS clinical trials research. The company has also received multiple Small Business Innovation Analysis grants from both National Science Foundation and the National Institutes of Wellness.. CMD co-founder receives Prize4Lifestyle award for discovery of new ALS biomarker Convergence Medical Products today announced that its co-founder, Dr. Seward Rutkove, Chief of the Division of Neuromuscular Disease at Beth Israel Deaconess Medical Center and Associate Professor of Neurology at Harvard Medical College, received Prize4Life’s prestigious award for the discovery of a new biomarker for ALS , also known as Lou Gehrig’s disease.He said that it ought not to become forgotten that Huntley by itself was in charge of the murders, as stated in the report. non-e of the activities or failures of any of the witnesses or the institutions they represented resulted in the deaths of the girls. Mr Blunkett added that it might be tough to disagree with Sir Michael’s look at that the ultimate responsibility for the critical failures in the senior management of Humberside Law enforcement rests with Chief Constable David Westwood. The strength of the report’s criticism of him offers led me to conclude that, using the powers open to me beneath the Police Act 1996, as amended by the Police Reform Act 2002, I will require Humberside Police Authority to suspend Mr Westwood as Chief Constable forthwith.